Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IRIDEX CORP Director's Dealing 2014

Dec 18, 2014

34978_dirs_2014-12-18_0388900d-c612-4946-8bfa-c41a62960a90.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IRIDEX CORP (IRIX)
CIK: 0001006045
Period of Report: 2014-12-17

Reporting Person: Steckel Ronald (VP, Operations)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2014-12-17 Common Stock M 625 $3.856 Acquired 2589 Direct
2014-12-17 Common Stock S 625 $8.5221 Disposed 1964 Direct
2014-12-17 Common Stock M 1025 $3.99 Acquired 2989 Direct
2014-12-17 Common Stock S 1025 $8.5221 Disposed 1964 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2014-12-17 Stock Option Right to Buy $3.856 M 625 Disposed 2017-01-01 Common Stock (625) Direct
2014-12-17 Stock Option Right to Buy $3.99 M 1025 Disposed 2016-04-16 Common Stock (1025) Direct

Footnotes

F1: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 Selling Plan adopted by the reporting person on 3/5/13.

F2: This option was granted pursuant to IRIDEX Corporation's 2008 Equity Incentive Plan and is exempt to Rule 16b-3.

F3: The shares are subject to vesting according to the following schedule: 1/48th of the total number of shares vest each month.

F4: The shares shall vest as follows: 12/48ths of the shares shall vest 12 months after the Vesting Commencement Date and 1/48th of the shares shall vest each month thereafter.